Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON

Leukemia. 2012 Jul;26(7):1726-9. doi: 10.1038/leu.2012.53. Epub 2012 Feb 23.

Authors

S Daenen, B van der Holt, A W Dekker, R Willemze, A W Rijneveld, B J Biemond, P Muus, A A van de Loosdrecht, H C Schouten, M van Marwijk Kooy, D A Breems, H Demuynck, J Maertens, P W Wijermans, S Wittebol, E W de Klerk, J J Cornelissen; HOVON; Dutch-Belgian Cooperative Group for Hematological Oncology

PMID: 22358264
DOI: 10.1038/leu.2012.53

No abstract available

Publication types

Clinical Trial, Phase II
Letter
Multicenter Study

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Feasibility Studies
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local / drug therapy*
Neoplasm Recurrence, Local / mortality*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality*
Prognosis
Prospective Studies
Survival Rate

Associated data

ISRCTN/ISRCTN00446029